CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 246 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03161899
NCT03161899N/ACompleted

Evaluation of Nutritional Status in Patients With Thalassemia Major in Assiut University Children Hospital

Assiut University·observational·Posted May 22, 2017·Updated Jul 30, 2020

In Brief

An observational study for Thalassemia Major. Completed, enrolled 246 participants across 1 site.

Detailed Summary

Thalassemia is a blood disorder passed down through families in which the body makes an abnormal form of hemoglobin. There are 2 main types of thalassemia; Alpha \& Beta thalassemia. Alpha thalassemia: occurs when a gene or genes related to the alpha globin protein are missing or mutated. Beta-thalassemia syndromes are a group of hereditary blood disorders characterized by reduced or absent beta globin chain synthesis. Beta-thalassemias can be classified into: Silent carrier: completely asymptomatic with normal hematological parameters. Beta-thalassaemia minor (beta-thalassaemia trait): usually asymptomatic; diagnosis is made during a work-up for mild anemia. Beta-thalassaemia intermedia: usually a similar presentation to beta-thalassaemia major; symptoms are usually less pronounced and the course is usually more insidious. Beta-thalassaemia major : In which there is complete absence of hemoglobin A

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesEgypt
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedMay 22, 2017
Enrollment StartDec 15, 2018
Primary CompletionMay 24, 2020
Study CompletionJul 20, 2020
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 9.1 years ago